DIABNEXT FINALIST OF THE PRIX GALIEN
The pitch competition organized by the Prix Galien distinguishes 8 finalists from more than 50 applications submitted, including DIABNEXT, the hassle-free diabetes monitoring solution.
Prix Galien contest 2018
Very honored by this nomination, Laurent NICOLAS states, “We will gradually deploy this technology integrating Artificial Intelligence. It will reinforce the potential of DIABNEXT, directing the solution towards opportunities to improve the management of diabetes that has not been considered.”
More specifically, this annual competition rewards and encourages innovative health projects. Thus, the scope of the price covers the innovations in health allowing
-to improve in the hospital: organization, coordination and/or quality of care
-to optimize care pathways and city-hospital relationships
The origins of the Prix Galien
In 1970, France created the Prix Galien focused on pharmaceutical research. Since then, the reputation and influence of the award have made it the world’s biggest distinction.
The Prix Galien aims to distinguish innovations in health (all therapies combined), as well as remarkable research work. In recent years, the award has honored innovations in all areas of health: medication, medical devices, patient support, and e-health.
Thus, this award helps to promote and energize health research and to encourage researchers and teams.
Prix Galien partners
It should be noted that the Galien competition benefits from a solid media partner in the world of health: the Profession Health Group (“Le Quotidien du Médecin” and “Le Quotidien du Pharmacien”). In addition, it relies on prestigious institutional partners, such as Medtronic, ASIP Santé, HEC Alumni Health Hub, Sanofi Genzyme …
Prix Galien international reputation
The public authorities, particularly the Ministers of Health, Research or Industry, have a particular interest in distinguished companies. In addition, the prize has an impact worldwide. As a result, laboratories and teams submit every year remarkable work and innovations.